Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02728258Phase 2Completed
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Endometrial Endometrioid AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+3 more
PrincipalinvestigatorStart date: 2016-09-16
NCT02257528Phase 2Active Not Recruiting
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma+3 more
PrincipalinvestigatorStart date: 2015-05-18

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Matthew S. Block, M.D., Ph.D.

Mayo Clinic in Rochester

Related
2 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaEndometrial Endometrioid Adenocarcinoma+3 more
Similarity Score15%

D. McMeekin

Gynecologic Oncology Group

Related
4 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaEndometrial Serous Adenocarcinoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Sharon Manne

Rutgers Cancer Institute of New Jersey

Related
5 trials

Shared therapeutic areas:

Stage IV Cervical Cancer AJCC v6 and v7Stage IVA Cervical Cancer AJCC v6 and v7Stage IVB Cervical Cancer AJCC v6 and v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

John K Chan

NRG Oncology

Related
3 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)NRG Oncology
Similarity Score8%

Bradley Monk

Gynecologic Oncology Group

Related
2 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Jyoti S Mayadev

NRG Oncology

Related
3 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaStage IVA Cervical Cancer AJCC v6 and v7

Worked with same sponsors:

National Cancer Institute (NCI)NRG Oncology
Similarity Score8%

Peter Rose

Gynecologic Oncology Group

Related
2 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Jermaine Coward

Integrated Haematology and Oncology Network

Related
2 trials

Shared therapeutic areas:

Endometrial Endometrioid AdenocarcinomaEndometrial Serous Adenocarcinoma
Similarity Score5%

Robert Coleman

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Endometrial Serous AdenocarcinomaEndometrial Undifferentiated Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Recurrent Cervical CarcinomaCervical Adenocarcinoma
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02728258Phase 2PrincipalInvestigator

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Endometrial Endometrioid AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+3 more
Completed
NCT02257528Phase 2PrincipalInvestigator

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma+3 more
Active Not Recruiting

All 2 trials loaded